Skip to main content
Home
Search
Multi-scale Atlas
NEW
Search for Drug ADMET Endpoint Profile (DAE)
NEW
Search for Drug Pharmacogenomic Perturbation Map (DPP)
NEW
Search for Drug-Molecule Activity Atlas (DMA)
NEW
Drug Development Portfolio
Search for Drug
Search for Combinatorial Drug (CBD)
Search for Repurposed Drug (RPD)
Drug-interacting Molecule
Search for Drug Therapeutic Target (DTT)
Search for Drug Transporter (DTP)
Search for Drug-Metabolizing Enzyme (DME)
Search for Drug Off-target (DOT)
Disease
Search for Disease
Download
Help
About
Details of the Drug Formulaction
General Information of Drug Formulation (ID: F02030)
Formulation Name
Atorvastatin 20 mg tablet
Company
NCS HealthCare of KY, Inc dba Vangard Labs
Pharmaceutical Drug(s) in Formulation
Drug Name
Drug ID
Indication
ICD 11
Status
Atorvastatin
DMF28YC
Acute coronary syndrome
BA41
Approved
--------------------
Pharmaceutical Excipient(s) in Formulation
Excipient Name
Excipient ID
PubChem CID
Functional Classification
Isopropyl alcohol
E00070
3776
Antimicrobial preservative; Solvent
Lactose monohydrate
E00393
104938
Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate
E00208
11177
lubricant
Sodium bicarbonate
E00424
516892
Alkalizing agent; Diluent
Sodium lauryl sulfate
E00464
3423265
Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Titanium dioxide
E00322
26042
Coating agent; Colorant; Opacifying agent
--------------------